Literature DB >> 23490249

Do tumor location and grade affect survival in pT2N0M0 esophageal squamous cell carcinoma?

Dongrong Situ1, Junye Wang, Peng Lin, Hao Long, Lanjun Zhang, Tiehua Rong, Guowei Ma.   

Abstract

BACKGROUND: The TNM staging system for esophageal cancer in the seventh edition of the AJCC Cancer Staging Manual incorporates tumor grade and location for staging pT2-3N0M0 esophageal squamous cell carcinoma. Patients with pT2N0M0, classified as stage IIA according to the sixth edition of the AJCC Cancer Staging Manual, can now be classified as stage IB, IIA, or IIB. We discuss whether these changes lead to a better prediction of the prognosis of these patients and aimed to find out other factors to forecast patient prognosis.
METHODS: We retrospectively analyzed 317 patients with postoperative pathologic stage T2N0M0 who underwent esophagectomy between 1990 and 2005 at Sun Yat-sen University Cancer Center. We performed univariate and multivariate analyses to identify prognostic factors for survival and used the Kaplan-Meier method to demonstrate the prognostic efficacy of each prognostic factor, including tumor grade and location.
RESULTS: The 5-year overall survival was 57%, with a median survival of 84.5 months (6.94 years). Univariate analysis indicated that age, alcohol consumption, and tumor grade were associated with survival. Multivariate Cox proportional hazard regression analysis revealed that alcohol consumption and tumor grade were independent prognostic factors. Survival analysis using the Kaplan-Meier method demonstrated age, cigarette smoking, alcohol consumption, tumor grade, and location as prognostic factors.
CONCLUSIONS: For pT2N0M0 esophageal squamous cell carcinoma, the seventh edition of the AJCC Cancer Staging Manual does not provide a more distinguishable prediction of prognosis compared with the sixth edition. Tumor grade is an independent prognostic factor in patients with pT2N0M0 esophageal squamous cell carcinoma, whereas tumor location is not. Furthermore, alcohol consumption is an independent prognostic factor that may imply a worse prognosis.
Copyright © 2013 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23490249     DOI: 10.1016/j.jtcvs.2013.01.034

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  13 in total

Review 1.  Postoperative radiation therapy of pT2-3N0M0 esophageal carcinoma-a review.

Authors:  Yijun Luo; Xiaoli Wang; Jinming Yu; Bin Zhang; Minghuan Li
Journal:  Tumour Biol       Date:  2016-09-18

2.  Evaluation of the 7th edition of the TNM classification in patients with resected esophageal squamous cell carcinoma.

Authors:  Jia Wang; Nan Wu; Qing-Feng Zheng; Shi Yan; Chao Lv; Shao-Lei Li; Yue Yang
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

3.  Evaluation of the 7(th) edition of the UICC-AJCC tumor, node, metastasis classification for esophageal cancer in a Chinese cohort.

Authors:  Yan Huang; Weigang Guo; Shiming Shi; Jian He
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

4.  Gross Tumor Volume Predicts Survival and Pathological Complete Response of Locally Advanced Esophageal Cancer After Neoadjuvant Chemoradiotherapy.

Authors:  Rong Wang; Xiaomei Zhou; Tongxin Liu; Shuimiao Lin; Yanxia Wang; Xiaogang Deng; Wei Wang
Journal:  Front Oncol       Date:  2022-06-07       Impact factor: 5.738

5.  Is the new distribution of early esophageal adenocarcinoma stages improving the prognostic prediction of the 8th edition of the TNM staging system for esophageal cancer?

Authors:  Ran Mo; Chen Chen; Liang Pan; Ao Yu; Dongjin Wang; Tao Wang
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

6.  Appropriateness of using patient-derived xenograft models for pharmacologic evaluation of novel therapies for esophageal/gastro-esophageal junction cancers.

Authors:  Lorin Dodbiba; Jennifer Teichman; Andrew Fleet; Henry Thai; Maud H W Starmans; Roya Navab; Zhuo Chen; Hala Girgis; Lawson Eng; Osvaldo Espin-Garcia; Xiaowei Shen; Bizhan Bandarchi; Joerg Schwock; Ming-Sound Tsao; Hala El-Zimaity; Sandy D Der; Wei Xu; Robert G Bristow; Gail E Darling; Paul C Boutros; Laurie E Ailles; Geoffrey Liu
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.240

7.  Endoscopic Tumor Length Should Be Reincluded in the Esophageal Cancer Staging System: Analyses of 662 Consecutive Patients.

Authors:  Michele Valmasoni; Elisa Sefora Pierobon; Alberto Ruol; Carlo Alberto De Pasqual; Gianpietro Zanchettin; Lucia Moletta; Renato Salvador; Mario Costantini; Stefano Merigliano
Journal:  PLoS One       Date:  2016-04-18       Impact factor: 3.240

8.  Early Esophageal Cancer Specific Survival Is Unaffected by Anatomical Location of Tumor: A Population-Based Study.

Authors:  Rajan N Amin; Samip J Parikh; Venu Gopala Reddy Gangireddy; Praveen Kanneganti; Swathi Talla; Sumanth Daram
Journal:  Can J Gastroenterol Hepatol       Date:  2016-07-31

Review 9.  Positive Effect of Higher Adult Body Mass Index on Overall Survival of Digestive System Cancers Except Pancreatic Cancer: A Systematic Review and Meta-Analysis.

Authors:  Jie Han; Yumei Zhou; Yuxiu Zheng; Miaomiao Wang; Jianfeng Cui; Pengxiang Chen; Jinming Yu
Journal:  Biomed Res Int       Date:  2017-08-29       Impact factor: 3.411

10.  The prognostic significance of celiac lymph node metastasis in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy.

Authors:  Yen-Hao Chen; Hung-I Lu; Yu-Ming Wang; Chien-Ming Lo; Shang-Yu Chou; Cheng-Hua Huang; Li-Hsueh Shih; Su-Wei Chen; Shau-Hsuan Li
Journal:  Oncotarget       Date:  2017-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.